Huan Guo

Dr. Huan Guo


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2021 in Annals of Medicine
Verified
Journal Article
Open access
XGXin Guan
Xin Guan
BZBo Zhang
Bo Zhang
MFMing Fu
Ming Fu
MLMengying Li
Mengying Li
XYXu Yuan
Xu Yuan
YLYanjun Lu
Yanjun Lu
To appraise effective predictors for COVID-19 mortality in a retrospective cohort study. A total of 1270 COVID-19 patients, including 984 admitted in Sino French New City Branch (training and inter...

1 July 2015 in Environmental Research
Verified
Journal Article
Closed access
TWTian Wang
Tian Wang
WFWei Feng
Wei Feng
DKDan Kuang
Dan Kuang
QDQifei Deng
Qifei Deng
WZWangzhen Zhang
Wangzhen Zhang
HGHuan Guo
Huan Guo

25 March 2014 in Environmental and Molecular Mutagenesis
Verified
Journal Article
Closed access
PDF file
HGHuan Guo
Huan Guo
KHKun Huang
Kun Huang
XZXiao Zhang
Xiao Zhang
WZWangzhen Zhang
Wangzhen Zhang
LGLei Guan
Lei Guan
TWTangchun Wu
Tangchun Wu

17 September 2018 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
JYJing Yang
Jing Yang
FWFei Wang
Fei Wang
JWJing Wang
Jing Wang
XHXu Han
Xu Han
HHHua Hu
Hua Hu
MHMeian He
Meian He
Emerging studies have investigated the association between different anthropometric indices with diabetes risk but the results were inconsistent. The aims of the study were to examine the associations of different anthropometric indices with incident diabetes risk and whether novel anthropometric indices improve diabetes prediction beyond traditional indices among elderly Chinese. Nine thousand nine hundred sixty-two elderly individuals (age ≥ 60 years old) derived from the prospective Dongfeng-Tongji cohort were included. Hazard ratio (HR) and corresponding 95% confidence interval (CI) were evaluated by Cox proportional hazard model to examine the associations between traditional anthropometric indices (body mass index [BMI], waist circumference [WC], waist-to-height ratio [WHtR]), novel anthropometric indices (visceral adiposity index [VAI], a body shape index [ABSI], body roundness index [BRI]) and diabetes risk. Receiver operating characteristic (ROC) curve and area under curve (AUC) were applied to compare the novel anthropometric indices with the traditional indices in diabetes prediction. During mean 4.6 years of follow-up, 614 incident cases of type 2 diabetes (T2D) were identified. Significant positive associations were detected between BMI, WC, WHtR, VAI and BRI and incident T2D risk. For ABSI, no significant association was observed in either men or women. BMI was the strongest predictor in diabetes in men (AUC = 0.655) comparable with the other anthropometric indices (P < 0.05). Similar as men, BMI was the strongest predictor (AUC = 0.635) in women. Except for WC, the AUC of BMI was larger than WHtR, VAI, and BRI. In contrast, ABSI was not a good predictor in either men (AUC = 0.507) or women (AUC = 0.503). In elderly Chinese, BMI, WC, WHtR, VAI and BRI were positively associated with incident T2D risk. Among them, BMI was the strongest predictor in both men and women.

1 August 2021 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
HMHua Meng
Hua Meng
GLGuyanan Li
Guyanan Li
WWWei Wei
Wei Wei
YBYansen Bai
Yansen Bai
YFYue Feng
Yue Feng
HGHuan Guo
Huan Guo

3 March 2017 in BMC Cancer
Verified
Journal Article
Open access
PDF file
JWJian-Zhong Wang
Jian-Zhong Wang
JXJing-Jun Xiang
Jing-Jun Xiang
LWLi-Ge Wu
Li-Ge Wu
YBYansen Bai
Yansen Bai
ZCZhuo-Wang Chen
Zhuo-Wang Chen
PXPing Xu
Ping Xu
Recently studies have demonstrated that the long non-coding RNA (lncRNA) metastasis associated lung adenocarcinoma transcript 1 (MALAT1) may participate in the development and progression of lung cancer. In this study, we hypothesized that genetic variant of this lncRNA may affect the prognosis of lung cancer patients. We conducted a follow-up study for 538 patients with non–small cell lung carcinoma (NSCLC), including 140 early-staged (stage I and II) and 398 advanced staged (stage III and IV) patients. The genetic variant rs3200401 in MALAT1 was then genotyped among this population by using TaqMan assay. The association of this variant with overall survival of these patients was further analyzed. It was shown that among the advanced lung adenoma patients, subjects carrying rs3200401 CT and CT + TT genotypes had significantly longer median survival time (MST = 29.9, 28.9 vs. 19.3 month, Long-rank P = 0.019 and 0.024, respectively) and decreased death risks [crude HR (95% CI) = 0.65 (0.43–0.98) and 0.64 (0.44–0.95), P = 0.040 and 0.025, respectively], when compared to subjects wtih the MALAT1 rs3200401 CC genotype. However, the beneficial effect of rs3200401 was not seen among early NSCLC and advanced lung squamous cell carcinoma patients. We further tested the TCGA data, and found that a higher expression of MALAT1 was associated with metastatic of advanced lung adenocarcinoma but not with lung squamous cell carcinoma. The rs3200401 T allele located on the lncRNA MALAT1 was associated with a better survival for advanced lung adenocarcinoma patients, which may offer a novel prognostic biomarker for this patient subgroup. However, these results need to be validated in larger populations of lung cancer and the biological function of this variant still warrants further investigation.